Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-119981
Filing Date
2022-11-17
Accepted
2022-11-17 18:53:17
Documents
1
Period of Report
2022-11-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2230762-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2230762-3_4seq1.xml 4 3399
  Complete submission text file 0001104659-22-119981.txt   4909
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Issuer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address
Migliarese Antonio (Reporting) CIK: 0001864040 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-49908 | Film No.: 221400115